SCHEMBL6832708

SCHEMBL6832708

Cc1ccc(N(C)C2(N(C)c3ccc(C)cc3)OC(=O)c3cc(Cl)ccc32)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.44
CYP3A4 P08684 1/20 0.44
HPGD P15428 1/20 0.44
HIF1A Q16665 1/20 0.44
HSD17B10 Q99714 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
ADCY2 Q08462 1/20 0.35
CES1 P23141 3/20 0.33
LMNA P02545 2/20 0.33
NPSR1 Q6W5P4 2/20 0.33
UTS2R Q9UKP6 1/20 0.33
HCAR2 Q8TDS4 1/20 0.33
TGM2 P21980 1/20 0.33
POLB P06746 2/20 0.32
MAPT P10636 1/20 0.32
ALOX12 P18054 1/20 0.32
GPR55 Q9Y2T6 1/20 0.32
PPOX P50336 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6834819 0.86 ALDH1A1 (0.56) ALDH1A1CYP3A4HPGDHIF1AHSD17B10
SCHEMBL4615007 0.84 MEN1 (0.55) ALDH1A1CYP3A4HPGDHIF1AHSD17B10
SCHEMBL6832673 0.82 ALDH1A1 (0.43) ALDH1A1CYP3A4HPGDHIF1AHSD17B10
SCHEMBL6829601 0.81 NPSR1 (0.43) ALDH1A1CYP3A4HPGDHIF1AHSD17B10
SCHEMBL221163 0.72 TDP1 (0.81) ALDH1A1CYP3A4HPGDHIF1AHSD17B10
SCHEMBL10933724 0.70 ALDH1A1 (0.65) ALDH1A1CYP3A4HPGDHIF1AHSD17B10
SCHEMBL12726666 0.69 TDP1 (0.79) ALDH1A1CYP3A4HPGDHIF1AHSD17B10
SCHEMBL12152338 0.67 ALDH1A1 (0.81) ALDH1A1CYP3A4HPGDHIF1AHSD17B10
SCHEMBL1892014 0.67 ALDH1A1 (0.59) ALDH1A1CYP3A4HPGDHIF1AHSD17B10
SCHEMBL5143698 0.66 ALDH1A1 (0.66) ALDH1A1CYP3A4HPGDHIF1AHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6747170-B2 LEUCO DYES; MOLECULE HAVING AT LEAST TWO AROMATIC RINGS, TWO CARBOXYL GROUPS, AND EITHER TWO AMIDES OR TWO ESTERS; PRESERVATION STABILITY RICOH COMPANY, LTD. (JP) 2004-06-08 US disclosed
US-20040071187-A1 Thermosensitive recording material and color developer compound therefor HAYAKAWA KUNIO (JP) 2004-04-15 US disclosed
US-6555705-B1 A supported thermosensitive recording layer containing a leuco dye and a color developer to induce color in the leuco dye upon heating; using 4-(2- or 4-phenoxyethoxy- or butoxy phthalic acid; image stability; oil, fat repellant RICOH COMPANY, LTD. (JP) 2003-04-29 US disclosed
US-6180560-B1 LEUCO DYE AND DYE DEVELOPER OF AROMATIC AMIDE OR ESTER; PRESERVATION STABILITY RICOH COMPANY, LTD. (JP) 2001-01-30 US disclosed
US-5583088-A ELECTRON DONOR, ELECTRON ACCEPTOR, DECOLORIZATION PROMOTER AGENT, BINDER RESIN RICOH COMPANY, LTD. (JP) 1996-12-10 US disclosed
EP-0612628-B1 Thermosensitive recording material using phthalic acid derivatives RICOH KK (JP) 1996-07-10 EP disclosed
US-5482912-A DEVELOPERS, THERMAL PRINTING, INTERMEDIATE LAYER OF THERMOPLASTIC HOLLOW SPHERES RICOH COMPANY, LTD. (JP) 1996-01-09 US disclosed
EP-0612628-A1 Thermosensitive recording material using phthalic acid derivatives Ricoh Company, Ltd (JP) 1994-08-31 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040071187-A1 Thermosensitive recording material and color developer compound therefor LRBA, THEM6, GOT1 ALDH1A1 274/4885CYP3A4 647/4885HPGD 1896/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.